SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-000585
Filing Date
2021-01-19
Accepted
2021-01-19 08:30:30
Documents
6
Period of Report
2021-01-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tenx_8k.htm 8-K 53078
2 AGREEMENT AND PLAN OF MERGER AMONG PHPRECISIONMED INC., TENAX THERAPEUTICS, INC. tenx_ex21.htm EX-2.1 557843
3 CERTIFICATE OF DESIGNATION OF SERIES B CONVERTIBLE PREFERRED STOCK tenx_ex41.htm EX-4.1 79106
4 EMPLOYMENT AGREEMENT WITH DR. STUART RICH DATED JANUARY 15, 2021 tenx_ex101.htm EX-10.1 147804
5 PRESS RELEASE DATED JANUARY 19, 2021 tenx_ex991.htm EX-99.1 23988
6 IMAGE logo.jpg GRAPHIC 4358
  Complete submission text file 0001654954-21-000585.txt   869731
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 21534021
SIC: 2834 Pharmaceutical Preparations